Cargando…
In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) is a problematic pathogen posing a serious therapeutic challenge in the clinic. It is often multidrug-resistant (MDR) to conventional classes of antibacterial agents and there is an urgent need to develop new agents or strategies for tre...
Autores principales: | Zuo, Guo-Ying, Zhang, Xin-Juan, Han, Jun, Li, Yu-Qing, Wang, Gen-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666064/ https://www.ncbi.nlm.nih.gov/pubmed/26627468 http://dx.doi.org/10.1186/s12906-015-0938-3 |
Ejemplares similares
-
Antimicrobial Effects and Resistant Regulation of Magnolol and Honokiol on Methicillin-Resistant Staphylococcus aureus
por: Kim, Su Young, et al.
Publicado: (2015) -
Antibacterial and Synergy of Berberines with Antibacterial Agents against Clinical Multi-Drug Resistant Isolates of Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Zuo, Guo-Ying, et al.
Publicado: (2012) -
Synergistic Antibacterial and Antibiotic Effects of Bisbenzylisoquinoline Alkaloids on Clinical Isolates of Methicillin-Resistant Staphylococcus Aureus (MRSA)
por: Zuo, Guo-Ying, et al.
Publicado: (2011) -
Disruption of Bacterial Thiol-Dependent Redox Homeostasis by Magnolol and Honokiol as an Antibacterial Strategy
por: Ouyang, Yanfang, et al.
Publicado: (2023) -
Synergism between Medihoney and Rifampicin against Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Müller, Patrick, et al.
Publicado: (2013)